1. A New Predictive Method for CO2-Oil Minimum Miscibility Pressure. (5th January 2021) Authors: Ge, Dangke; Cheng, Haiying; Cai, Mingjun; Zhang, Yang; Dong, Peng Other Names: Yu Wei Academic Editor. Journal: Geofluids Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A New Predictive Method for CO2-Oil Minimum Miscibility Pressure. (5th January 2021) Authors: Ge, Dangke; Cheng, Haiying; Cai, Mingjun; Zhang, Yang; Dong, Peng Other Names: Yu Wei Academic Editor. Journal: Geofluids Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cell cycle inhibitors for the treatment of NSCLC. (May 2014) Authors: Shcherba, Marina; Liang, Yuanxin; Fernandes, David; Perez-Soler, Roman; Cheng, Haiying Journal: Expert opinion on pharmacotherapy Issue: Volume 15:Number 7(2014) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Could erlotinib be used in EGF receptor wild-type non-small-cell lung cancer?. (October 2013) Authors: Cheng, Haiying; Piperdi, Bilal Journal: Lung cancer management Issue: Volume 2:Number 5(2013) Page Start: 333 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Detection of plasma EGFR mutations for personalized treatment of lung cancer patients without pathologic diagnosis. (28th January 2020) Authors: Deng, Qinfang; Fang, Qiyu; Sun, Hui; Singh, Aditi P.; Alexander, Mariam; Li, Shenduo; Cheng, Haiying; Zhou, Songwen Journal: Cancer medicine Issue: Volume 9:Number 6(2020) Page Start: 2085 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non–Small Cell Lung Cancer. (January 2020) Authors: Sukrithan, Vineeth; Barbaro, Alexander; Chergui, Adel; Ko, Brian; Lin, Juan; Cheng, Haiying; Goel, Sanjay Journal: American journal of clinical oncology Issue: Volume 43:Number 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Do Patients Regret Having Received Systemic Treatment for Advanced Non‐Small Cell Lung Cancer: A Prospective Evaluation. (10th November 2020) Authors: Hollen, Patricia J.; Gralla, Richard J.; Gentzler, Ryan D.; Hall, Richard D.; Coyne, Bethany; Cheng, Haiying; Halmos, Balazs; Gildersleeve, Jane; Calderon, Claudia; Hinton, Ivora; Weiss, Geoffrey; Crawford, Jeffrey; Cerise, Jane; Lesser, Martin Journal: Oncologist Issue: Volume 26:Number 3(2021) Page Start: 224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Emerging drugs for EGFR-mutated non-small cell lung cancer. (2nd January 2019) Authors: Sukrithan, Vineeth; Deng, Lei; Barbaro, Alexander; Cheng, Haiying Journal: Expert opinion on emerging drugs Issue: Volume 24:Number 1(2019) Page Start: 5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Emerging drugs for squamous cell lung cancer. (March 2015) Authors: Cheng, Haiying; Shcherba, Marina; Kandavelou, Karthikeya; Liang, Yuanxin; Liu, Huijie; Perez-Soler, Roman Journal: Expert opinion on emerging drugs Issue: Volume 20:Number 1(2015:Mar.) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Emerging treatment for ALK-positive lung cancer. (2nd April 2016) Authors: Sharma, Janaki; Pareek, Vipul; Liu, Huijie; Cheng, Haiying Journal: Expert opinion on emerging drugs Issue: Volume 21:Number 2(2016:Jun.) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗